FilingSEC EDGAR8-K
Serina Therapeutics Files Certificate of Elimination for Series A Convertible Preferred Stock
· SEC accepted
StageCompleted
Filing content
Following the conversion of all outstanding Series A Convertible Preferred Stock into common stock, the company filed a Certificate of Elimination to remove the designation from its certificate of incorporation.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…